People who received a personalized melanoma skin cancer vaccine on top of a standard treatment were less likely to die over the study period than those who had the standard treatment alone
Custom-made cancer vaccines that prime an individual’s immune system to attack the unique biology of their tumor have halted the progression of melanoma skin cancer in almost half the people taking part in a randomized clinical trial.
Continued Article: https://www.newscientist.com/article/2351872-personalised-melanoma-vaccines-prolong-survival-in-largest-trial-yet/
